The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

Jun. 29, 2015
Applicant:

Dose Medical Corporation, Laguna Hills, CA (US);

Inventors:

Hosheng Tu, Newport Coast, CA (US);

Barbara A. Niksch, Capistrano Beach, CA (US);

David S. Haffner, Mission Viejo, CA (US);

Gregory T. Smedley, Aliso Viejo, CA (US);

Olav B. Bergheim, Laguna Hills, CA (US);

Morteza Gharib, Altadena, CA (US);

Richard A. Hill, Irvine, CA (US);

Thomas W. Burns, Dana Point, CA (US);

Assignee:

DOSE MEDICAL CORPORATION, Laguna Hills, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/007 (2006.01); A61F 9/00 (2006.01); A61L 27/54 (2006.01); A61M 27/00 (2006.01);
U.S. Cl.
CPC ...
A61F 9/00781 (2013.01); A61F 9/0017 (2013.01); A61L 27/54 (2013.01); A61M 27/002 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/258 (2013.01); A61L 2300/41 (2013.01); A61L 2300/414 (2013.01); A61L 2300/416 (2013.01); A61L 2300/42 (2013.01); A61L 2430/16 (2013.01);
Abstract

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.


Find Patent Forward Citations

Loading…